Voya Investment Management LLC I Teos Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Dec 06, 2024	BUY	$9.89 - $13.64 $200,885 - $277,055	20,312 New	20,312 $277,000
Q1 2024 May 15, 2024	SELL	$9.89 - $13.64 $18,514 - $25,534	-1,872 Reduced 8.44%	20,312 $277,000
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $4,478 - $5,971	409 Added 1.88%	22,184 $242,000
Q2 2023 Aug 14, 2023	BUY	$12.93 - $18.05 $281,550 - $393,038	21,775 New	21,775 $288,000
Q2 2022 Aug 15, 2022	SELL	$16.57 - $35.1 $132,278 - $280,203	-7,983 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$26.23 - $47.86 $8,078 - $14,740	-308 Reduced 3.71%	7,983 $372,000
Q1 2021 May 17, 2021	BUY	$30.86 - $44.2 $255,860 - $366,462	8,291 New	8,291 $283,000

166

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $257M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.